Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Gris

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ<sub>1-42</sub>-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's diseaseMehdi Alami, Echarki Zerif, Abdelouahed Khalil, et al.
Cancer Biology & Therapy|December 3, 2025
Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapyRyma Haroun, Cleopatra Rutihinda, Aissatou Hadja Diallo, et al.
Immunity|June 28, 2011
NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathwaysIrving C Allen, Chris B Moore, Monika Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2010
Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivityJanelle C Arthur, John D Lich, Zhengmao Ye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2010
Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensisMax Tze-Han Huang, Brittany L Mortensen, Debra J Taxman, et al.
Plos Biology|September 17, 2019
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunityMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2011
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresMansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, et al.
Plos Genetics|June 7, 2019
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of diseaseCarles Vilariño-Güell, Alexander Zimprich, Filippo Martinelli-Boneschi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Alzheimer'S Disease : JAD|March 20, 2025
Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ<sub>1-42</sub>-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's diseaseMehdi Alami, Echarki Zerif, Abdelouahed Khalil, et al.
Cancer Biology & Therapy|December 3, 2025
Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapyRyma Haroun, Cleopatra Rutihinda, Aissatou Hadja Diallo, et al.
Immunity|June 28, 2011
NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathwaysIrving C Allen, Chris B Moore, Monika Schneider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2010
Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivityJanelle C Arthur, John D Lich, Zhengmao Ye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2010
Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensisMax Tze-Han Huang, Brittany L Mortensen, Debra J Taxman, et al.
Plos Biology|September 17, 2019
NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunityMarjan Gharagozloo, Shaimaa Mahmoud, Camille Simard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2011
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresMansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, et al.
Plos Genetics|June 7, 2019
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of diseaseCarles Vilariño-Güell, Alexander Zimprich, Filippo Martinelli-Boneschi, et al.
Pageof 5